121 related articles for article (PubMed ID: 16077924)
1. A putative role for histone deacetylase in the differentiation of human erythroid cells.
Fujieda A; Katayama N; Ohishi K; Yamamura K; Shibasaki T; Sugimoto Y; Miyata E; Nishi K; Masuya M; Ueda H; Nakajima H; Shiku H
Int J Oncol; 2005 Sep; 27(3):743-8. PubMed ID: 16077924
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis.
Yamamura K; Ohishi K; Katayama N; Yu Z; Kato K; Masuya M; Fujieda A; Sugimoto Y; Miyata E; Shibasaki T; Heike Y; Takaue Y; Shiku H
Br J Haematol; 2006 Oct; 135(2):242-53. PubMed ID: 16939493
[TBL] [Abstract][Full Text] [Related]
3. [EPO mediated proliferation and differentiation of human erythroid progenitor inhibited by FK228].
Yu ZC; Liu WC; Fan L; Oishi K; Katayama N
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):575-7. PubMed ID: 17553359
[TBL] [Abstract][Full Text] [Related]
4. [FK228 promotes the IL-3 mediated proliferation and differentiation of human erythroid progenitor cells].
Yu ZC; Liu WC; Liu DH; Huang Y; Shi XM; You XH; Chen Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):672-5. PubMed ID: 18616908
[TBL] [Abstract][Full Text] [Related]
5. Parallel regulation of PKC-alpha and PKC-delta characterizes the occurrence of erythroid differentiation from human primary hematopoietic progenitors.
Lanuti P; Bertagnolo V; Gaspari AR; Ciccocioppo F; Pierdomenico L; Bascelli A; Sabatino G; Miscia S; Marchisio M
Exp Hematol; 2006 Dec; 34(12):1624-34. PubMed ID: 17157158
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation.
Savickiene J; Treigyte G; Borutinskaite V; Navakauskiene R; Magnusson KE
Ann N Y Acad Sci; 2006 Dec; 1091():368-84. PubMed ID: 17341629
[TBL] [Abstract][Full Text] [Related]
8. Vanadate elevates fetal hemoglobin in human erythroid precursors by inhibiting cell maturation.
Amoyal I; Prus E; Fibach E
Exp Biol Med (Maywood); 2007 May; 232(5):654-61. PubMed ID: 17463162
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.
Hoshino I; Matsubara H; Hanari N; Mori M; Nishimori T; Yoneyama Y; Akutsu Y; Sakata H; Matsushita K; Seki N; Ochiai T
Clin Cancer Res; 2005 Nov; 11(21):7945-52. PubMed ID: 16278420
[TBL] [Abstract][Full Text] [Related]
10. Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines.
Xiao JJ; Huang Y; Dai Z; Sadée W; Chen J; Liu S; Marcucci G; Byrd J; Covey JM; Wright J; Grever M; Chan KK
J Pharmacol Exp Ther; 2005 Jul; 314(1):467-75. PubMed ID: 15833893
[TBL] [Abstract][Full Text] [Related]
11. A small-scale serum-free liquid cell culture model of erythropoiesis to assess the effects of exogenous factors.
Cheung JO; Casals-Pascual C; Roberts DJ; Watt SM
J Immunol Methods; 2007 Jan; 319(1-2):104-17. PubMed ID: 17174973
[TBL] [Abstract][Full Text] [Related]
12. Depsipeptide-resistant KU812 cells show reversible P-glycoprotein expression, hyper-acetylated histones, and modulated gene expression profile.
Yamada H; Arakawa Y; Saito S; Agawa M; Kano Y; Horiguchi-Yamada J
Leuk Res; 2006 Jun; 30(6):723-34. PubMed ID: 16260035
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
[TBL] [Abstract][Full Text] [Related]
14. Codevelopment of dendritic cells along with erythroid differentiation from human CD34(+) cells by tumor necrosis factor-alpha.
Fukaya H; Xiao W; Inaba K; Suzuki Y; Hirokawa M; Kawabata Y; Komatsuda A; Endo T; Kishimoto H; Takada G; Sawada K
Exp Hematol; 2004 May; 32(5):450-60. PubMed ID: 15145213
[TBL] [Abstract][Full Text] [Related]
15. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.
Kanao K; Mikami S; Mizuno R; Shinojima T; Murai M; Oya M
J Urol; 2008 Sep; 180(3):1131-6. PubMed ID: 18639283
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
17. FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities.
Konstantinopoulos PA; Vandoros GP; Papavassiliou AG
Cancer Chemother Pharmacol; 2006 Nov; 58(5):711-5. PubMed ID: 16435156
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in proliferating human erythroid cells.
Gubin AN; Njoroge JM; Bouffard GG; Miller JL
Genomics; 1999 Jul; 59(2):168-77. PubMed ID: 10409428
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
[TBL] [Abstract][Full Text] [Related]
20. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
